Assessment of absolute blood volume in carcinoma by USPIO contrast-enhanced MRI
- PMID: 16563957
- DOI: 10.1016/j.mri.2005.12.003
Assessment of absolute blood volume in carcinoma by USPIO contrast-enhanced MRI
Abstract
Objectives: The characterization of tumor vasculature is essential in studying tumor physiology. The aim of this study was to develop a new method - based on water proton MR density measurements, in combination with ultrasmall superparamagnetic iron oxide (USPIO) administration - to measure absolute blood volume (BV) in murine colon carcinoma.
Materials and methods: MRI experiments were performed at 7 T. CPMG imaging was performed on subcutaneous murine colon carcinoma in six mice before and after administration of an USPIO blood-pool contrast agent. Density maps were obtained from the signal amplitude at TE=0 of the CPMG decay fit. Post-USPIO density maps were subtracted from pre-USPIO density maps to quantitatively yield absolute tumor BV maps. In a separate group of mice (n=6), the relative vascular area (RVA) of tumors was determined by immunohistochemistry.
Results: Ultrasmall superparamagnetic iron oxide administration resulted in a small decrease in the water proton MR density. The BV averaged over the six tumors was 4.6+/-1.6%. The value of the RVA measured by immunohistochemical staining was equal to 3.9+/-2.2%.
Conclusions: After administration of an USPIO blood-pool agent (T(2) relaxivity > 100 mM(-1) s(-1)), the blood water protons become MRI invisible, and pixel-by-pixel BV map can be obtained by subtracting the calculated post-USPIO density map from the pre-USPIO density map. The value of absolute BV obtained with this novel MR approach is in good agreement with the value of the relative vascular measured by immunohistochemical staining.
Similar articles
-
Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice.Radiology. 2003 Nov;229(2):429-38. doi: 10.1148/radiol.2292021007. Radiology. 2003. PMID: 14595147
-
Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.Radiology. 2007 Aug;244(2):449-56. doi: 10.1148/radiol.2442060371. Epub 2007 Jun 11. Radiology. 2007. PMID: 17562810
-
Decrease of signal intensity of myometrium and cervical stroma after ultrasmall superparamagnetic iron oxide (USPIO) particles administration: an MR finding with potential benefits in T staging of uterine neoplasms.Invest Radiol. 2004 Nov;39(11):666-70. doi: 10.1097/00004424-200411000-00004. Invest Radiol. 2004. PMID: 15486527 Clinical Trial.
-
USPIO-Enhanced MRI Neuroimaging: A Review.J Neuroimaging. 2016 Mar-Apr;26(2):161-8. doi: 10.1111/jon.12318. Epub 2015 Dec 3. J Neuroimaging. 2016. PMID: 26932522 Review.
-
[Iron-oxide-enhanced MR imaging of inflammatory atherosclerotic lesions: overview of experimental and initial clinical results].Rofo. 2003 Apr;175(4):469-76. doi: 10.1055/s-2003-38434. Rofo. 2003. PMID: 12677500 Review. German.
Cited by
-
Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.Eur J Nucl Med Mol Imaging. 2018 May;45(5):759-767. doi: 10.1007/s00259-017-3890-2. Epub 2017 Nov 21. Eur J Nucl Med Mol Imaging. 2018. PMID: 29164301 Free PMC article.
-
Molecular magnetic resonance imaging approaches used to aid in the understanding of angiogenesis in vivo: implications for tissue engineering.Tissue Eng Part A. 2010 Feb;16(2):357-64. doi: 10.1089/ten.TEA.2009.0233. Tissue Eng Part A. 2010. PMID: 19663584 Free PMC article.
-
Repeatability and sensitivity of T2* measurements in patients with head and neck squamous cell carcinoma at 3T.J Magn Reson Imaging. 2016 Jul;44(1):72-80. doi: 10.1002/jmri.25134. Epub 2016 Jan 22. J Magn Reson Imaging. 2016. PMID: 26800280 Free PMC article.
-
Functional MRI and CT biomarkers in oncology.Eur J Nucl Med Mol Imaging. 2015 Apr;42(4):562-78. doi: 10.1007/s00259-014-2979-0. Epub 2015 Jan 13. Eur J Nucl Med Mol Imaging. 2015. PMID: 25578953 Review.
-
Comparison of T2 and T2*-weighted MR molecular imaging of a mouse model of glioma.BMC Med Imaging. 2013 Jul 18;13:20. doi: 10.1186/1471-2342-13-20. BMC Med Imaging. 2013. PMID: 23865826 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical